Send to a Friend Font Size: Increase Decrease

Carl Icahn

Carl Icahn's Portfolio

Ticker	# of Shares	Price	Value
IEP	79,238,262	$35.70	$2,828,805,954
MSI	38,292,235	$46.40	$1,776,759,704
EP	65,983,829	$25.79	$1,701,722,950
MMI	33,505,706	$38.65	$1,294,995,537
FDML	75,980,915	$14.21	$1,079,688,803
CLX	12,039,196	$65.50	$788,567,338
FRX	26,083,088	$29.75	$775,971,868
CLX	7,098,678	$65.50	$464,963,409
CLX	6,587,378	$65.50	$431,473,259
HAIN	7,130,563	$37.99	$270,890,089
View Additional Portfolio Information »

http://www.icahnreport.com/

Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.

Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.

Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.

In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.

In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.

Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.

In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.

Login to help us fill in information about this entity.

Carl Icahn Files Q3 13F Nov 14, 2011 05:55PM

Carl Icahn Liquidates Biogen Idec (BIIB), Chesapeake Energy (CHK); Targets Oshkosh (OSK), Forest Labs (FRX) and Commercial Metals (CMC) Aug 15, 2011 06:24PM

Jefferies Lifts Price Target on and Estiamtes On Forest Laboratories (FRX) Jul 20, 2011 07:27AM

Carl Icahn Amends 'Item 3' in 13D on Forest Labs (FRX) Jun 24, 2011 03:44PM

Forest Labs (FRX) Shares on the Move as Co. Hires Advisers to Help Defend Against Icahn Jun 23, 2011 02:20PM

Jun 20, 2011 01:01PM Collins Stewart Raises Price Target on Forest Laboratories (FRX) Following Carl Icahn's 13D Filing
Jun 17, 2011 03:52PM Forest Labs (FRX) Shares Rising as Icahn Discloses Purchase of Calls, May Continue to Seek Talks with Mgmt; Shows 6.95% Stake
Jun 13, 2011 02:06PM Notable 52-Week Highs and Lows of the Day 06/13: (ORS) (INSM) (FRX) High; (NOK) (RIMM) (BZH) Low
Jun 13, 2011 07:33AM Carl Icahn Seeks Four for Forest Laboratories (FRX) Board
May 16, 2011 04:57PM Icahn's Icahn Capital Shows New Stake in Amgen (AMGN), Clorox (CLX) and Southern Union (NYSE: SUG); Raises Dynegy (DYN), Lowers Chesapeake (CHK)
Feb 25, 2011 04:04PM Top 10 News Items 2/22-2/25: Crude Cracks the $100/Barrel Level; Latest Q4 GDP Reading Worse-Than-Expected at 2.8%; HP Tumbles on Earnings, Outlook
Feb 22, 2011 10:17AM Morning Movers 02/22: (FONR) (TTHI) (SIGA) (ZRAN) Higher; (DCTH) (DAKT) (AMOT) Lower
Feb 22, 2011 09:11AM Pre-Open Movers 2/22: (ZRAN) (MENT) (CHK) (HD) Higher; (DCTH) (CLDA) (WMT) Lower
Nov 15, 2010 05:39PM Icahn Hangs on to Pharmas, Makes Housing Play, Increases Lions Gate Holding in Recent 13F (MOT, MAS, HAIN, More...)
Feb 15, 2010 10:15PM Carl Icahn Raises Stakes In Take-Two (TTWO) and Genzyme (GENZ), Slashes Stake in Yahoo! (YHOO)
Jan 25, 2010 11:34AM Forest Labs (FRX) Developing Drugs, and Potential Profits, for Investors - Barron's
Jul 31, 2008 10:14AM Biotech Takeover Buzz Hot and Heavy After ImClone Offer (ONXX, OSIP, BIIB, AMLN, XPNT, CYPB, ISPH)

Carl Icahn

Carl Icahn's Portfolio

Free News Feed